drugset / Trial / NCT04714099

Topical Cyclosporine A for the Treatment of Dry Eye: A Randomized Clinical Study

NCT04714099

Phase 3 Completed 40 enrolled Alexandria University
RandomizedParallel-groupSingle-blindTreatment

Summary

Since the initial description, the therapeutic efficacy of CsA for human KCS has been well documented, with evidence ranging from several small single center randomized double-masked clinical trials to several large multicenter randomized, double-masked clinical trials.(10-12) Therefore, the aim of the work is to evaluate the effect of using topical CsA in treatment of moderate to severe dry eye.

Timeline

Start
2015-01-01
Primary completion
2015-12-01
Completion
2015-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide 0.05 % Topical

Indications